GL1X · GenesisL1 explorer

MolNFT v1 · #137091 · protein

Crystal structure of human glycine receptor alpha-3 bound to am-3607, glycine, and ivermectin

5VDH · Glycine receptor subunit alpha-3: “Crystal structure of human glycine receptor alpha-3 bound to am-3607, glycine, and ivermectin”. X-ray diffraction, 6 ligands (7C6, GLY, IVM), 20 pockets (best druggability 0.79). MolNFT v1 #137091…

PDB
5VDH
Type
protein
Length
1,700 residues
Chains
5
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycine receptor subunit alpha-3
UniProt
O75311
Ligands
7C6, GLY, IVM, NAG, ZN, CL
Pockets
20 · best druggability 0.79

Structure

x-ray diffraction · 3 distinct chains · 36% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C, EGlycine receptor subunit alpha-3protein33836% helix, 30% strandO75311
BGlycine receptor subunit alpha-3protein34337% helix, 29% strandO75311
DGlycine receptor subunit alpha-3protein34336% helix, 29% strandO75311

Ligands and binding sites

  • 7C6 · (3s,3as,9bs)-2-[(2H-1,3-benzodioxol-5-yl)sulfonyl]-3,5-dimethyl-1,2,3,3A,5,9B-hexahydro-4H-pyrrolo[3,4-C][1, 6]naphthyridin-4-one · ligand · 5 copies · chains A, B, C, D, E
  • GLY · Glycine · ligand · 5 copies · chains A, B, C, D, E
  • IVM · (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar, 20BS)-6'-[(2S)-butan-2-yl]-20,20B-dihydroxy-5',6,8,19-tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17A, 20,20A,20B-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside · ligand · 5 copies · chains A, B, C, D, E
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains C
  • ZN · Zinc ion · metal · 5 copies · chains A, B, C, D, E
  • CL · Chloride ion · ion

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 15 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18240.790.82887C6
25550.790.8546CL
34370.710.82467C6
44280.710.82437C6
54040.710.82477C6

Interfaces

5 interfaces between chains.

  • B–C · 2391 Ų buried · 19 hydrogen bonds · protein-protein
  • C–D · 2378 Ų buried · 17 hydrogen bonds · protein-protein
  • A–B · 2376 Ų buried · 18 hydrogen bonds · protein-protein
  • A–E · 2358 Ų buried · 16 hydrogen bonds · protein-protein
  • D–E · 2353 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 5VDH · Crystal Structure of Human Glycine Receptor alpha-3 Bound to AM-3607, Glycine, and… · the same entry in another collection · chain E against E, TM-score 1.00
  • O75311 · AlphaFold monomer V2.0 prediction for glycine receptor subunit alpha-3 (O75311) · a predicted model of the same protein · chain C against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.